A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
Public ClinicalTrials.gov record NCT03086460. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the dose-response of different doses of CHF 1531 pressurized metered dose inhaler (pMDI) containing formoterol fumarate, on lung function and other clinical outcomes and to identify the optimal dose(s) with regard to benefit/ risk ratio for further development in the target subject population.
Study identification
- NCT ID
- NCT03086460
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 67 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 7, 2017
- Primary completion
- Jul 22, 2018
- Completion
- Jul 27, 2018
- Last update posted
- Aug 15, 2021
2017 – 2018
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Chiesi Investigational Site | Tucson | Arizona | 85710 | — |
| Chiesi Investigational Site | Los Angeles | California | 90048 | — |
| Chiesi Investigational Site | Lutherville | Maryland | 21093 | — |
| Chiesi Investigational Site | St Louis | Missouri | 63141 | — |
| Chiesi Investigational Site | Raleigh | North Carolina | 27607 | — |
| Chiesi Investigational Site | Greenville | South Carolina | 29615 | — |
| Chiesi Investigational Site | Orangeburg | South Carolina | 29118 | — |
| Chiesi Investigational Site | Spartanburg | South Carolina | 29303 | — |
| Chiesi Investigational Site | Knoxville | Tennessee | 37909 | — |
| Chiesi Investigational Site | Richland | Washington | 99352 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03086460, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 15, 2021 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03086460 live on ClinicalTrials.gov.